Newsroom | 1853 results
Sorted by: Latest
-
Indication BioScience Reports First Human Evidence That Atorvo+™ May Improve Statin Tolerability
DENVER--(BUSINESS WIRE)--Indication BioScience, a clinical-stage biopharmaceutical company developing next-generation combination therapies for cardiometabolic disease, today announced encouraging early findings from its ongoing Phase I study of Atorvo+™. The investigational therapy combines atorvastatin — the world’s most prescribed cholesterol-lowering statin — with a proprietary orally active solid form of cannabidiol. Atorvo+™ is being developed as a first-line statin therapy, designed to i...
-
Sweetspot Dispensary Brings Premium Cannabis Retail to River Edge, NJ
RIVER EDGE, N.J.--(BUSINESS WIRE)--Sweetspot Farms, a cannabis company with dispensaries and sustainable cultivation operations across the Northeast and Mid-Atlantic, today announced the grand opening of its newest dispensary at 75 Route 4, River Edge, NJ 07661. The River Edge dispensary caters to a wide range of adult-use consumers with Sweetspot’s modern and approachable store design, which showcases available strains and provides details on THC, cannabinoids, and dominant terpenes for a more...
-
High Times Magazine Celebrates 50 Years With New Editor-In-Chief, Return of the Cannabis Cup & Print Issue
NEW YORK--(BUSINESS WIRE)--High Times, the iconic voice in cannabis culture, psychedelics, advocacy and industry insight, proudly announces the release of its limited-edition, collectible 50th Anniversary Issue, the appointment of award-winning journalist Javier Hasse as its new Editor-in-Chief and the long-awaited return of the Cannabis Cup. Together, these milestones mark five decades of cannabis journalism, culture and community, while heralding a new era. Founded in 1974, High Times became...
-
The Cannabist Company Partners with Queen Mary to Launch Wellness-Focused Cannabis Products in Colorado
CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced its partnership with Queen Mary, an award-winning California wellness-focused cannabis brand known for formulations that blend plant medicine with natural supplements. Queen Mary's signature Sativa Rosin and Indica Rosin gummies will...
-
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates...
-
Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) today announced that, due to the requisite quorum not being present, the annual general and special meeting of shareholders (the “Meeting”) scheduled for September 26, 2025 at 1:00 p.m. Eastern Time via live webcast was convened and then adjourned. The Meeting has been adjourned until October 10 at 1:00 PM ET and will be held via live audio webcast at www.virtualsharehold...
-
Bipartisan Lawmakers Urge Congressional Leaders to Oppose Hemp Ban
WASHINGTON--(BUSINESS WIRE)--With the threat of prohibition still looming over the $28.4 billion hemp industry, 35 Members of Congress sent joint letters to leadership urging strong opposition to the inclusion of hemp-killing language in any final spending package. Instead, lawmakers are calling for the passage of responsible, effective regulations aimed at protecting consumers and supporting a growing American industry. In a letter spearheaded by Representative James Comer (R-KY) and Represent...
-
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company” or “Anebulo”), today announces the first subjects dosed in its Phase 1 single ascending dose (“SAD”) study of intravenous (IV) selonabant in healthy young adults. The study is supported by a collaborative grant from the National Institute on Drug Abuse (NIDA). First Subjec...
-
The Cannabist Company Holdings Inc. Announces Voting Results of Annual General Meeting of Shareholders
CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today that, at the annual general meeting (the “Meeting”) of shareholders of the Company (“Shareholders”) that was held on Wednesday, September 24, 2025, all seven nominees for the board of directors of the Company were elected...
-
Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general and special meeting of shareholders (the “Meeting”) to September 26, 2025 at 9:00 AM ET. The Meeting will be held later the same day, at 1:00 PM ET via live audio webcast at www.virtualshareholdermeeting.com/WEED2025. The deadline is being extended to all...